HighTower Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.11M | Sell |
20,250
-5,023
| -20% | -$206K | ﹤0.01% | 2171 |
|
|
2026
Q1 | $840K | Buy |
25,273
+1,991
| +9% | +$59.3K | ﹤0.01% | 2310 |
|
|
2025
Q4 | $694K | Sell |
23,282
-4,511
| -16% | -$147K | ﹤0.01% | 2383 |
|
|
2025
Q3 | $1M | Buy |
27,793
+4,143
| +18% | +$136K | ﹤0.01% | 2093 |
|
|
2025
Q2 | $851K | Buy |
23,650
+759
| +3% | +$28.3K | ﹤0.01% | 2121 |
|
|
2025
Q1 | $903K | Buy |
22,891
+7,979
| +54% | +$268K | ﹤0.01% | 2030 |
|
|
2024
Q4 | $449K | Buy |
14,912
+2,386
| +19% | +$68.5K | ﹤0.01% | 2554 |
|
|
2024
Q3 | $294K | Buy |
12,526
+2,053
| +20% | +$44.8K | ﹤0.01% | 2828 |
|
|
2024
Q2 | $186K | Sell |
10,473
-67
| -0.6% | -$1.07K | ﹤0.01% | 3055 |
|
|
2024
Q1 | $160K | Buy |
10,540
+65
| +0.6% | +$1.03K | ﹤0.01% | 3046 |
|
|
2023
Q4 | $180K | Sell |
10,475
-188
| -2% | -$2.19K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $90K | Sell |
10,663
-523
| -5% | -$7.29K | ﹤0.01% | 3121 |
|
|
2023
Q2 | $277K | Sell |
11,186
-2,539
| -18% | -$65.6K | ﹤0.01% | 2621 |
|
|
2023
Q1 | $207K | Sell |
13,725
-1,577
| -10% | -$24K | ﹤0.01% | 2732 |
|
|
2022
Q4 | $181K | Sell |
15,302
-1,226
| -7% | -$8.9K | ﹤0.01% | 2801 |
|
|
2022
Q3 | $98K | Sell |
16,528
-75
| -0.5% | -$492 | ﹤0.01% | 2770 |
|
|
2022
Q2 | $69K | Buy |
16,603
+3,000
| +22% | +$18.7K | ﹤0.01% | 2860 |
|
|
2022
Q1 | $129K | Buy |
13,603
+2,998
| +28% | +$34.7K | ﹤0.01% | 2938 |
|
|
2021
Q4 | $202K | Sell |
10,605
-10,479
| -50% | -$272K | ﹤0.01% | 2771 |
|
|
2021
Q3 | $701K | Sell |
21,084
-85
| -0.4% | -$2.63K | ﹤0.01% | 1860 |
|
|
2021
Q2 | $822K | Buy |
21,169
+5,225
| +33% | +$205K | ﹤0.01% | 1761 |
|
|
2021
Q1 | $768K | Buy |
15,944
+1,041
| +7% | +$50K | ﹤0.01% | 1725 |
|
|
2020
Q4 | $780K | Sell |
14,903
-1,272
| -8% | -$43K | ﹤0.01% | 1396 |
|
|
2020
Q3 | $433K | Sell |
16,175
-1,524
| -9% | -$35.1K | ﹤0.01% | 1641 |
|
|
2020
Q2 | $345K | Sell |
17,699
-500
| -3% | -$8.05K | ﹤0.01% | 1646 |
|
|
2020
Q1 | $179K | Sell |
18,199
-38,283
| -68% | -$484K | ﹤0.01% | 1823 |
|
|
2019
Q4 | $631K | Buy |
56,482
+39,382
| +230% | +$299K | ﹤0.01% | 1346 |
|
|
2019
Q3 | $96K | Buy |
17,100
+2,500
| +17% | +$17.4K | ﹤0.01% | 2170 |
|
|
2019
Q2 | $127K | Sell |
14,600
-2,000
| -12% | -$15.1K | ﹤0.01% | 2133 |
|
|
2019
Q1 | $133K | Buy |
16,600
+500
| +3% | +$2.7K | ﹤0.01% | 2030 |
|
|
2018
Q4 | $66K | Buy |
16,100
+750
| +5% | +$3.73K | ﹤0.01% | 2008 |
|
|
2018
Q3 | $85K | Buy |
15,350
+950
| +7% | +$10.9K | ﹤0.01% | 2080 |
|
|
2018
Q2 | $189K | Hold |
14,400
| – | – | ﹤0.01% | 1916 |
|
|
2018
Q1 | $204K | Buy |
14,400
+3,000
| +26% | +$38.3K | ﹤0.01% | 1867 |
|
|
2017
Q4 | $93K | Buy |
11,400
+300
| +3% | +$2.62K | ﹤0.01% | 2043 |
|
|
2017
Q3 | $132K | Sell |
11,100
-300
| -3% | -$3.42K | ﹤0.01% | 1981 |
|
|
2017
Q2 | $114K | Sell |
11,400
-3,906
| -26% | -$43.7K | ﹤0.01% | 1942 |
|
|
2017
Q1 | $170K | Buy |
+15,306
| New | +$110K | ﹤0.01% | 1801 |
|
Other funds holding TGTX
SCM
CAM
HighTower Advisors's TGTX Position: Q2 2026 in Review
HighTower Advisors reduced its TG Therapeutics (TGTX) stake by 20% in Q2 2026, selling an estimated $206K and leaving 20,250 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2171.
HighTower Advisors first reported a position in TGTX in Q1 2017 and has held it in 38 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- HighTower Advisors held 20,250 shares of TG Therapeutics worth $1.11M as of Q2 2026.
- HighTower Advisors sold 5,023 TG Therapeutics shares in Q2 2026, an estimated $206K.
- TG Therapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2171 holding.
- HighTower Advisors first reported a position in TG Therapeutics in Q1 2017 and has held it in 38 quarters since.
- 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.